Many European companies are keen to enter the China market and develop long-term partnerships in China. They are often willing to transfer their latest technology to Chinese subsidiaries.
It is not hard to sense it from interviews over the past two years with the drug multinationals that are struggling to find a way out by minimizing potential losses.
京公网安备 11010802020770号